about
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013.Age and gender distribution of hepatitis C virus genotypes in the metropolitan area of Naples.The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B.Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients.The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy.Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients.Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection.Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.Influence of chronic coinfection with hepatitis B and C virus on liver histology.Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases.Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma.Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection.Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection.Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study.Lower long-term mortality within a regional system of care for ST-elevation myocardial infarctionReactivation of overt and occult hepatitis B infection in various immunosuppressive settingsLiver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitisComplications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsiesAzathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosisSerum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitisEfficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients
P50
Q37090659-C7442EC4-6F96-4616-B42B-3E65B8182E1BQ38952987-BA30186B-E3A4-4A4F-AEB3-0B903C3F3B3EQ40105729-37919452-14F2-4221-ADD7-530722F26685Q41443935-FB3D009F-522A-4E3A-8169-8AA502710770Q42196360-D0ABD29A-1A0D-4547-AFC3-3732C8ED327FQ42201054-FB93082C-A5CE-4D45-B810-55C0B4690E29Q42222997-2335BD1A-AE45-4B95-B864-96CFE40D7EE9Q42255783-1535BE9C-45EF-459A-AFDB-003462B0B75CQ42266477-1FC935AE-8C3C-4936-9270-A19B2AE67C5FQ42985571-AACA8923-85A0-4720-97FE-1AD8AA25FC01Q42991587-2BA1CBC2-0326-4909-99B3-A6D99CA50BCDQ43085980-6ECB47DB-08A3-46E1-90EE-990AD8E94E6AQ43605323-6C590F3A-3858-4AF0-8644-3AE1968FBAD7Q45355787-8C04B1CE-BE3D-4C50-992C-8166A73B0338Q45405567-C58C4E15-8477-4EEA-9DFC-BCC9381675DBQ50707984-21A15CD9-6DA8-499C-B5E0-7C643C514676Q54490638-427B907F-2601-4DBB-8E42-36F14E721FE4Q54523160-80259D88-DFCD-4E10-8A15-2803A77958E1Q56988410-4F19A6C6-D704-4C06-A87E-32DD402DA228Q60232557-C3776B52-1769-4F65-ADED-D15A0D1C5668Q60232583-620D6734-73E1-4958-B584-289587B0AAA5Q70032258-304B9352-80B2-409E-B912-2FD57A596073Q71707650-E1107BAB-BDF7-424B-A864-392E5EF41EBBQ72429104-F25F6DEB-96FC-4C8A-B17A-6FDECA695115Q73492923-B73F71C6-0E2D-4289-99F0-4BEC69639E96
P50
description
researcher ORCID ID = 0000-0002-5427-4504
@en
wetenschapper
@nl
name
Giuseppe Pasquale
@ast
Giuseppe Pasquale
@en
Giuseppe Pasquale
@es
Giuseppe Pasquale
@nl
type
label
Giuseppe Pasquale
@ast
Giuseppe Pasquale
@en
Giuseppe Pasquale
@es
Giuseppe Pasquale
@nl
prefLabel
Giuseppe Pasquale
@ast
Giuseppe Pasquale
@en
Giuseppe Pasquale
@es
Giuseppe Pasquale
@nl
P1153
9742254800
P21
P31
P496
0000-0002-5427-4504